Atlas Trials

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Clinical trial NCT04635111 · RECRUITING

Trial details

NCT number
NCT04635111
Sponsor
Daiichi Sankyo
Status
RECRUITING
Study type
OBSERVATIONAL
HepatotoxicityTenosynovial Giant Cell Tumor
Start date
2021-01-07
Primary completion
2036-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.